Tus kws kho mob
2018 May Bulletins
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 01, 2018
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 3231 - 3240 ntawm 4138
Tus kws kho mob
P72-17 New Availity Functionality Available to Create and Submit an Electronic Referral
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 17, 2017
Tus kws kho mob
P73-17 A New Drug, Hemlibra (emicizumab) Will Require Prior Authorization
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 28, 2017
Tus kws kho mob
P14-17 Medical Drug Management
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 10, 2017
Tus kws kho mob
P29-17 New Drug-Related Prior Authorization (PA) Criteria: Erythropoietins
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 05, 2017
Tus kws kho mob
P25-17 Addition of New Drugs to the Hepatitis C Second Generation Antivirals Prior Authorization (PA) with Quantity Limit (QL) Program
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 25, 2017
Tus kws kho mob
P23-17 Change to Administration of Interpreter Services for MHCP Subscribers
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 16, 2017
Tus kws kho mob
P12-17 A New Drug, Pharmaceutical Grade L-Glutamine Will Require Prior Authorization
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 03, 2017
Tus kws kho mob
P28-17 New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Hereditary Angioedema
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 25, 2017
Tus kws kho mob
P3-17 Added Reimbursement Policies
Hnub Tim pib siv tau lub khoos kas: Lub Ib Hlis Ntuj 27, 2017